 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
June 2, 2014 2:09 PM
|
Dendritic Cell Vaccine Improved PFS, Not OS in Glioblastoma
Cancer Network
The regimen consisted of four induction doses of the vaccine after chemoradiation, and then maintenance doses until disease progression.
|
|
Scooped by
Gilbert C FAURE
June 1, 2014 2:41 PM
|
Genmab A/S - Genmab Announces Ofatumumab Development Plans in RRMS ...
|
|
Scooped by
Gilbert C FAURE
May 31, 2014 4:59 AM
|
New Trials Testing Agents for Treating Relapsing-Remitting Multiple Sclerosis HCPLive DALLAS -- May 29, 2014 -- A plethora of new agents may soon be available for treating relapsing-remitting multiple sclerosis, according to information presented...
|
|
Scooped by
Gilbert C FAURE
May 29, 2014 3:44 PM
|
Genetic studies have provided the best evidence for cause and effect relationships in Alzheimer's disease (AD).
|
|
Scooped by
Gilbert C FAURE
May 29, 2014 2:55 PM
|
Guidance TA312 Alemtuzumab for treating relapsing‑remitting multiple sclerosis (RT @AETSA_: #NICE_Publica #GPC Alemtuzumab en esclerosis multiple recurrente-remitente http://t.co/uEJpTvAvTT)...
|
|
Scooped by
Gilbert C FAURE
May 28, 2014 3:15 PM
|
RT @infdisease_news: #FASEB Summer Research Conference on Translational Neuroimmunology in Big Sky, Montana http://t.co/xuIs85kWZ4
|
|
Scooped by
Gilbert C FAURE
May 27, 2014 12:59 PM
|
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023 PR Newswire (press release) Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to...
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 3:45 PM
|
Glatiramer acetate (GA) (Copaxone), a well-established drug for the treatment of multiple sclerosis, is believed to modulate numerous pathways including antigen-presenting cells or cytokine responses.
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 3:44 PM
|
Glioblastoma (GBM) is an aggressive disease associated with poor survival. It is essential to account for the complexity of GBM biology to improve diagnostic and therapeutic strategies.
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 3:07 PM
|
Research and Markets: Receptos' RPC1063 for multiple sclerosis
Business Wire (press release)
Sphingosine-1 phosphate (S1P) is a bioactive sphingolipid that promotes lymphocyte survival, cell migration, and inflammation.
|
|
Scooped by
Gilbert C FAURE
May 23, 2014 3:16 PM
|
Correspondence from The New England Journal of Medicine — Bevacizumab for Newly Diagnosed Glioblastoma ((NEJM) Bevacizumab for Newly Diagnosed Glioblastoma http://t.co/sRVOyogRqf)...
|
|
Scooped by
Gilbert C FAURE
May 22, 2014 2:06 PM
|
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
May 22, 2014 1:52 PM
|
Background:Congenital toxoplasmosis can result in visual impairment, hearing loss, serious neurologic sequelae and death in the infant.
|
|
|
Scooped by
Gilbert C FAURE
June 2, 2014 5:55 AM
|
Alemtuzumab: Do the Benefits Outweigh the Risks in Treating Multiple Sclerosis?
|
|
Scooped by
Gilbert C FAURE
June 1, 2014 2:41 PM
|
Genmab A/S - Genmab Announces Ofatumumab Development Plans in RRMS ...
|
|
Scooped by
Gilbert C FAURE
May 31, 2014 4:52 AM
|
The present study was designed to test the hypothesis that Cr2-/- mice, which lack the receptors CR2/CD21 and CR1/CD35 for complement C3-derived activation fragments, are protected from adverse sequelae of ...
|
|
Scooped by
Gilbert C FAURE
May 29, 2014 2:59 PM
|
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
May 29, 2014 2:53 PM
|
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world.
|
|
Scooped by
Gilbert C FAURE
May 28, 2014 3:13 PM
|
Choroid Plexus - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References Free Download PDF. This is a 3-in-1 reference book.
|
|
Scooped by
Gilbert C FAURE
May 25, 2014 2:26 PM
|
OBJECTIVES: Alemtuzumab is a newly licensed treatment of active relapsing-remitting multiple sclerosis (RRMS) in Europe, which in phase II and III studies demonstrated superior efficacy over β-interferon in reducing ...
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 3:44 PM
|
Over ninety years ago, Kolmer and Agduhr identified spinal cerebrospinal fluid-contacting neurons (CSF-cNs) based on their morphology and location within the spinal cord. In more than two hundred v...
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 3:11 PM
|
Research and Markets: Biogen-Idec's Anti-LINGO-1: 2014 Report Business Wire (press release) These drugs act to suppress lymphocyte subsets, reduce trafficking of immune cells across the blood-brain-barrier, and/or to cause autoreactive cells to be...
|
|
Scooped by
Gilbert C FAURE
May 24, 2014 11:04 AM
|
Can you remind us of the EU Joint Programme – Neurodegenerative Disease Research (JPND)'s core objectives and expand on its vision to tackle the challenge of neurodegenerative diseases? JPND is the largest global ...
|
|
Scooped by
Gilbert C FAURE
May 23, 2014 9:49 AM
|
by Arijit Ghosh, Thomas Birngruber, Wolfgang Sattler, Thomas Kroath, Maria Ratzer, Frank Sinner, Thomas R. Pieber
Blood-brain barrier (BBB) impairment in systemic inflammation leads to neuroinflammation.
|
|
Scooped by
Gilbert C FAURE
May 22, 2014 2:05 PM
|
Phase I trial of a humanized anti-GD2 antibody in recurrent or refractory neuroblastoma http://t.co/G1QuEy95ZA #neuroblastoma #oncology
|
Scoop.it!
